DiscoverDISRxUPTEpisode 17 | Advancing Compounding Technology - Joe D'Silva and Will Boyko
Episode 17 | Advancing Compounding Technology - Joe D'Silva and Will Boyko

Episode 17 | Advancing Compounding Technology - Joe D'Silva and Will Boyko

Update: 2022-04-15
Share

Description

Joe D'Silva, founder, CEO, and CSO of Patient & Consumers (P&C) Pharma, has always had an eye toward developing high-quality pharmaceutical products. Driven by a passion for enhancing personalized patient care and a vision to take the technology used in the pharmaceutical industry into the pharmacy itself, Joe left roles in the pharmaceutical industry to found P&C Pharma. Through this work, Joe developed QuartetRx, a first-in-class oral liquid compounding device that leverages wet milling technology to produce consistent oral liquid medications without the need for manual compounding. In this episode of DISRxUPT, Will Boyko, consultant pharmacist with P&C Pharma, along with Joe D'Silva, join us to discuss their journey of taking QuartetRx from a dream to a reality and the ways in which this technology can benefit both patients and pharmacists. We will also discuss how current and future pharmacists can be change agents in the profession.

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Episode 17 | Advancing Compounding Technology - Joe D'Silva and Will Boyko

Episode 17 | Advancing Compounding Technology - Joe D'Silva and Will Boyko

Cedarville University Center for Pharmacy Innovation